semaglutide once weekly (NN9904) / Novo Nordisk  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
semaglutide once weekly (NN9904) / Novo Nordisk
NCT05521256: A Research Study of a New Medicine NNC0113-6856 in Healthy Males

Completed
1
70
Europe
NNC0113-6856, Placebo
Novo Nordisk A/S
Healthy Volunteers, Type 2 Diabetes
03/23
03/23
NCT06069895: Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

Recruiting
1
170
Europe
NNC0113-6856, Placebo
Novo Nordisk A/S
Healthy Participants
06/25
06/25

Download Options